{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:04:23Z","timestamp":1790773463066,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1136\/ard.2011.149922","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T00:49:24Z","timestamp":1314060564000},"page":"2155-2158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["On-demand anakinra treatment is effective in mevalonate kinase deficiency"],"prefix":"10.1016","volume":"70","author":[{"given":"E J","family":"Bodar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P H","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W M","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2011.149922_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2011.149922_bib2","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","article-title":"HMG-CoA reductase inhibition induces IL-1beta release through Rac1\/PI3K\/PKB-dependent caspase-1 activation.","volume":"112","author":"Kuijk","year":"2008","journal-title":"Blood"},{"key":"10.1136\/ard.2011.149922_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/ard.2011.149922_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2010.01974.x","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review of therapy with biological drugs and case report.","volume":"100","author":"Korppi","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1136\/ard.2011.149922_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2796.2010.02313.x","article-title":"Blocking interleukin-1\u03b2 in acute and chronic autoinflammatory diseases.","volume":"269","author":"Dinarello","year":"2011","journal-title":"J Intern Med"},{"key":"10.1136\/ard.2011.149922_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2011.149922_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2009.11.001","article-title":"Therapy of autoinflammatory syndromes","volume":"124","author":"Hoffman","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard.2011.149922_bib8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.142.12.1591","article-title":"Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1\/NALP3 mutations.","volume":"142","author":"Leslie","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1136\/ard.2011.149922_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2011.149922_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.30149","article-title":"Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome.","volume":"63","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.149922_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome.","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.149922_bib12","first-page":"260","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth J Med"},{"key":"10.1136\/ard.2011.149922_bib13","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/rheumatology\/kem258","article-title":"Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.","volume":"46","author":"Lequerr\u00e9","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2011.149922_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-006-0408-7","article-title":"Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.","volume":"29","author":"Cailliez","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2011.149922_bib15","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1542\/peds.2006-2015","article-title":"Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency.","volume":"119","author":"Nevyjel","year":"2007","journal-title":"Pediatrics"},{"key":"10.1136\/ard.2011.149922_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","article-title":"Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome.","volume":"27","author":"Rigante","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2011.149922_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672419053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672419053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2011.149922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:07:31Z","timestamp":1737248851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672419053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S000349672419053X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2011.149922","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2011.149922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}